Replies to post #6272 on Generex Biotechnology Corp. (fka GNBTQ)

[otced]

Be very careful with GNBT they sell News. Been hearing about Prostate and breast cancer vaccination for 10years now Phase 2. KEYTRUDA® (pembrolizumab) Is nothing new from Merck. they will license anyone to play with it. GNBT strength is NEW news and 1M A/S share's only. Share holders need to ask for conformation about share structure this guys are know for share INCREASE AND STOCK SPLITS. Look at stock split history > If shares are increased to 1B like before ...... RDGL is a better play cancer wise . Testing and diagnostic I leave it to Quest labs for life.